Sep 25, 2011, 10:20 p.m.

Breast cancer study shows benefits of double therapy

STOCKHOLM (Reuters) - Giving breast cancer patients radiotherapy and chemotherapy at the same time significantly cuts the risk their tumors will come back and should be considered as a new treatment approach across the world, cancer experts said on Sunday. The double treatment, known as synchronous chemoradiation, could also save lives among people with breast cancer, a disease that currently kills 425,000 women a year worldwide, according to the British experts who conducted a major scientific study.

Cancer study boosts hopes for Roche's armed antibody

STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data from a mid-stage clinical trial of the new combination drug, trastuzumab emtansine (T-DM1), in HER2-positive breast cancer found patients given T-DM1 had a 41 percent improvement in the time without their breast cancer worsening compared with those given trastuzumab, or Herceptin, plus chemotherapy.

Kansas firm recalls cantaloupe linked to Listeria outbreak

(Reuters) - A Kansas-based food processor recalled hundreds of pounds of fresh-cut cantaloupe on Friday because of possible Listeria contamination linked to melons from Colorado that were blamed for an outbreak that has killed eight people. Carol's Cuts was recalling 594 pounds of cantaloupe packaged in 5-pound trays and as an ingredient in fruit medleys distributed in Kansas, Missouri and Nebraska, a recall notice posted on the U.S. Food and Drug Administration website said.

Editor's Picks

Most Recent